Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 Sep 20 424B4 Prospectus supplement with pricing info
- 29 Sep 20 EFFECT Notice of effectiveness
- 28 Sep 20 F-1/A Registration statement (foreign) (amended)
- 25 Sep 20 FWP Free writing prospectus
- 25 Sep 20 F-1/A Registration statement (foreign) (amended)
- 25 Sep 20 FWP Free writing prospectus
- 24 Sep 20 F-1/A Registration statement (foreign) (amended)
- 23 Sep 20 FWP Free writing prospectus
- 23 Sep 20 F-1/A Registration statement (foreign) (amended)
- 21 Sep 20 F-1/A Registration statement (foreign) (amended)
-
4 Sep 20 F-1 Registration statement (foreign)
ORPHY similar filings
Filing view
External links
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 30, 2020, except for Notes 3.1 and 3.7, as to which the date is August 5, 2020, with respect to the consolidated financial statements of Orphazyme A/S for the years ended December 31, 2019 and 2018, included in the Registration Statement (Form F-1) and related Prospectus of Orphazyme A/S for the registration of its common shares.
/s/ EY Godkendt Revisionspartnerselskab (formerly Ernst & Young P/S)
Copenhagen, Denmark
September 4, 2020